source
- Travere appoints former Amicus CEO Bradley Campbell as new chief executiveTravere Therapeutics CEO Eric Dube is stepping down after overseeing the launch of the rare kidney disease drug Filspari. Bradley Campbell will assume the role on Dec 1, bringing experience from l…
- AI doomsday warnings may curb health-tech innovation, Epic cautionsRecent commentary warns that sensational AI doomsday predictions could slow the pace of health‑technology innovation. Epic, the large electronic health‑record company that provides AI tools to hos…